Tradestie Institutional Equity Comparison Engine

AHG vs PSAI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AHG Overall Edge

AHG Captures Institutional Edge (1โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Akso Health Group ADS (AHG) driven by superior Growth & Margin while PSAI counters with relative strength in Momentum & Technical. Fundamentally, AHG trades at N/M Forward P/E with -28.9% operating margin (-12.9% YoY revenue) versus PSAI at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, AHG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PSAI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
AHG N/M vs PSAI N/M Fwd P/E
Growth & Margin Winner AHG
Op Margin -28.9% vs N/A ยท YoY -12.9% vs N/A
Momentum & Technical Winner PSAI
1Y -15.3% vs +14.3% ยท 52W Pos 36% vs 91%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
AHG NASDAQ
Akso Health Group ADS
Services-Business Services, Nec
$1.33
+7.26% 1D
Market Cap $1.1B
1M Return -1.48%
1Y Return -15.29%
Forward P/E N/M
Unified AI Score
42.6 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
PSAI US Equity
PSAI
Institutional Equity
$29.30
-0.86% 1D
Market Cap N/A
1M Return +1.91%
1Y Return +14.29%
Forward P/E N/M
Unified AI Score
54.8 / 100 HOLD
Tech 55.0 Fund 56.0 Flow 50.0 Mom 41.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AHG -15.29% PSAI +14.29% Spread: +49.41 pp (PSAI Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AHG TTM Op. Margin: -28.9% PSAI TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AHG vs PSAI. Trailing 12-month operating profitability (AHG -28.9% vs PSAI N/A) and valuation multiples (AHG N/M vs PSAI N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AHG (5) vs PSAI (3)
Institutional Metric AHG PSAI Criterion Row Winner
Market Capitalization Scale $1.1B N/A Larger Scale AHG
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -12.9% N/A Higher Growth AHG
Operating Margin (TTM) Profitability -28.9% N/A Higher Margin AHG
Net Profit Margin Profitability -135.0% N/A Higher Margin AHG
Return on Equity (ROE) Capital Efficiency -9.8% N/A Higher ROE AHG
52-Week Range Position Momentum 36% ($1โ€“$2) 91% ($25โ€“$30) Stronger Trend PSAI
Beta / 30D Volatility Risk Regime 0.16ฮฒ ยท 97% Vol 0.80ฮฒ ยท 13% Vol Lower Realized Risk PSAI
Unified Institutional Score Composite Signal 42.6 / 100 (HOLD) 54.8 / 100 (HOLD) Higher Composite PSAI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AHG vs PSAI Buy Guide
AHG UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AHG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PSAI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PSAI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AHG nor PSAI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.